Movatterモバイル変換

[0]ホーム
URL:

GB201120711D0 - Method for classifying tumour cells - Google Patents

Method for classifying tumour cells

Info

Publication number
GB201120711D0
GB201120711D0GB201120711AGB201120711AGB201120711D0GB 201120711 D0GB201120711 D0GB 201120711D0GB 201120711 AGB201120711 AGB 201120711AGB 201120711 AGB201120711 AGB 201120711AGB 201120711 D0GB201120711 D0GB 201120711D0
Authority
GB
United Kingdom
Prior art keywords
classifying
tumour cells
classes
nsclc
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201120711A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erasmus University Medical Center
Original Assignee
Erasmus University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus University Medical CenterfiledCriticalErasmus University Medical Center
Priority to GB201120711ApriorityCriticalpatent/GB201120711D0/en
Publication of GB201120711D0publicationCriticalpatent/GB201120711D0/en
Priority to PCT/EP2012/004957prioritypatent/WO2013079215A1/en
Ceasedlegal-statusCriticalCurrent

Links

Landscapes

Abstract

The invention relates to a method for preparing an optimised gene signature for assigning a NSCLC sample to one or more NSCLC classes, comprising subjecting a gene signature set forth in Table 12 herein to nearest shrunken centroid analysis to identify one or more subgroups of gene classifiers corresponding to one or more of classes 1 to 6 identified in Table 12, and validating the performance of the selected classifiers by K-fold or leave-one-out cross-validation.
GB201120711A2011-12-012011-12-01Method for classifying tumour cellsCeasedGB201120711D0 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
GB201120711AGB201120711D0 (en)2011-12-012011-12-01Method for classifying tumour cells
PCT/EP2012/004957WO2013079215A1 (en)2011-12-012012-11-30Method for classifying tumour cells

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB201120711AGB201120711D0 (en)2011-12-012011-12-01Method for classifying tumour cells

Publications (1)

Publication NumberPublication Date
GB201120711D0true GB201120711D0 (en)2012-01-11

Family

ID=45509031

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB201120711ACeasedGB201120711D0 (en)2011-12-012011-12-01Method for classifying tumour cells

Country Status (2)

CountryLink
GB (1)GB201120711D0 (en)
WO (1)WO2013079215A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP2867368B1 (en)*2012-07-062022-01-12Institut Gustave RoussySimultaneous detection of cannibalism and senescence as prognostic marker for cancer
JP2015529808A (en)*2012-07-242015-10-08シーダーズ−サイナイ メディカル センター A novel method for detecting resistance to chemotherapy in patients with lung cancer
US11408887B2 (en)2017-05-222022-08-09The National Institute for Biotechnology in the Negev Ltd.Biomarkers for diagnosis of lung cancer
CN112159661B (en)*2020-08-312022-09-27南昌航空大学 Preparation method and application of rare earth upconversion fluorescent probe for detecting DNA damage markers
CN113096730B (en)*2021-04-022022-02-25中山大学Prediction system for nasopharyngeal carcinoma molecular typing

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4631211A (en)1985-03-251986-12-23Scripps Clinic & Research FoundationMeans for sequential solid phase organic synthesis and methods using the same
US4683195A (en)1986-01-301987-07-28Cetus CorporationProcess for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en)1985-03-281987-07-28Cetus CorporationProcess for amplifying nucleic acid sequences
US5567588A (en)1990-06-111996-10-22University Research CorporationSystematic evolution of ligands by exponential enrichment: Solution SELEX
US5270163A (en)1990-06-111993-12-14University Research CorporationMethods for identifying nucleic acid ligands
US5654151A (en)1990-06-111997-08-05Nexstar Pharmaceuticals, Inc.High affinity HIV Nucleocapsid nucleic acid ligands
US5503978A (en)1990-06-111996-04-02University Research CorporationMethod for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
US5837832A (en)1993-06-251998-11-17Affymetrix, Inc.Arrays of nucleic acid probes on biological chips
WO1996038579A1 (en)1995-06-021996-12-05Nexstar Pharmaceuticals, Inc.High-affinity oligonucleotide ligands to growth factors
US6403311B1 (en)1997-02-122002-06-11Us GenomicsMethods of analyzing polymers using ordered label strategies
EP1009802B1 (en)1997-02-122004-08-11Eugene Y. ChanMethods for analyzimg polymers
ATE374815T1 (en)1997-07-072007-10-15Medical Res Council METHOD OF INCREASE THE CONCENTRATION OF NUCLIC ACID MOLECULES
US6790671B1 (en)1998-08-132004-09-14Princeton UniversityOptically characterizing polymers
US6263286B1 (en)1998-08-132001-07-17U.S. Genomics, Inc.Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer
US6210896B1 (en)1998-08-132001-04-03Us GenomicsMolecular motors
GB9900298D0 (en)1999-01-071999-02-24Medical Res CouncilOptical sorting method
US6818395B1 (en)1999-06-282004-11-16California Institute Of TechnologyMethods and apparatus for analyzing polynucleotide sequences
US6440706B1 (en)1999-08-022002-08-27Johns Hopkins UniversityDigital amplification
US6762059B2 (en)1999-08-132004-07-13U.S. Genomics, Inc.Methods and apparatuses for characterization of single polymers
US6696022B1 (en)1999-08-132004-02-24U.S. Genomics, Inc.Methods and apparatuses for stretching polymers
AU7086800A (en)1999-08-302001-03-26Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, TheHigh speed parallel molecular nucleic acid sequencing
GB0022458D0 (en)2000-09-132000-11-01Medical Res CouncilDirected evolution method
US7194269B2 (en)2000-10-302007-03-20Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of IndustryMethod and wireless communication hub for data communications
GB0127564D0 (en)2001-11-162002-01-09Medical Res CouncilEmulsion compositions
DE602004026033D1 (en)2003-01-292010-04-29454 Corp SECONDARY SEQUENCING
CA2531105C (en)2003-07-052015-03-17The Johns Hopkins UniversityMethod and compositions for detection and enumeration of genetic variations
WO2005039389A2 (en)2003-10-222005-05-06454 CorporationSequence-based karyotyping
US7169560B2 (en)2003-11-122007-01-30Helicos Biosciences CorporationShort cycle methods for sequencing polynucleotides
WO2005054431A2 (en)2003-12-012005-06-16454 CorporationMethod for isolation of independent, parallel chemical micro-reactions using a porous filter
ES2432040T3 (en)2004-01-282013-11-29454 Life Sciences Corporation Nucleic acid amplification with continuous flow emulsion
JP2007532610A (en)2004-04-162007-11-15エヴォテック ニューロサイエンシス ゲゼルシャフト ミット ベシュレンクテル ハフツング Diagnostic and therapeutic uses of KCNC1 for neurodegenerative diseases
EP2201135A2 (en)*2007-09-282010-06-30Duke UniversityIndividualized cancer treatments

Also Published As

Publication numberPublication date
WO2013079215A1 (en)2013-06-06

Similar Documents

PublicationPublication DateTitle
EP4379578A3 (en)Learning situations via pattern matching
EP3683321A3 (en)Methods relating to circulating tumor cell clusters and the treatment of cancer
AU2018256508A1 (en)Individualized vaccines for cancer
GB201120711D0 (en)Method for classifying tumour cells
WO2013014667A3 (en)System and methods for computerized machine-learning based authentication of electronic documents including use of linear programming for classification
BR112016026575A2 (en) Mirna Expression Signature in Thyroid Tumor Classification
EP2650780A3 (en)Component discovery from source code
EP4234711A3 (en)Methods and materials for assessing homologous recombination deficiency
EP4129061A3 (en)Systems, apparatus and methods for analyzing blood cell dynamics
EP2485428A3 (en)Efficient, remote, private tree-based classification using cryptographic techniques
EA201791443A1 (en) NATURAL KILLER CELLS AND THEIR APPLICATIONS
MX362983B (en)Systems and methods for facial representation.
WO2013102026A3 (en)Method and system for video composition
MX2015009780A (en)Systems and methods for clinical decision support.
IN2014DN09363A (en)
MX2016004286A (en)Cancer biomarkers and uses thereof.
WO2014085776A3 (en)Web search ranking
EP2991003A3 (en)Method and apparatus for classification
IN2014DN08017A (en)
WO2014145751A3 (en)Targeted therapies for cancer
EP3780661A3 (en)Metadata-preserved audio object clustering
GB2550777A (en)Classification and storage of documents
WO2012109202A3 (en)Methods and apparatus for processing documents
WO2015093948A3 (en)Means and methods for typing a breast cancer patient and assigning therapy based on the typing
EP2693356A3 (en)Detecting pirated applications

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp